• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两例经皮冠状动脉介入治疗中应用注射混合Histoacryl(正丁基-2-氰基丙烯酸酯)和Lipiodol(碘油)治疗冠状动脉穿孔的病例。

Two Cases of Management of Coronary Artery Perforation During Percutaneous Coronary Intervention Using Injection of Combined Histoacryl (n-Butyl-2-Cyanoacrylate) and Lipiodol (Ethiodized Oil).

机构信息

Department of Cardiology, 108 Central Military Hospital, Hanoi, Vietnam.

Vinuniversity College of Health Sciences, Hanoi, Vietnam.

出版信息

Am J Case Rep. 2023 Feb 3;24:e938861. doi: 10.12659/AJCR.938861.

DOI:10.12659/AJCR.938861
PMID:36733227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9901490/
Abstract

BACKGROUND Coronary artery perforation is a rare complication of percutaneous coronary intervention for coronary artery occlusion. This report is of 2 cases of coronary artery perforation during percutaneous coronary intervention that were managed successfully using injection of combined Histoacryl (n-Butyl-2-Cyanoacrylate) and Lipiodol (ethiodized oil). CASE REPORT Case 1 was a 51-year-old man with a past medical history of hypertension, dyslipidemia, and multivessel coronary disease. He was admitted to our hospital with inferior wall myocardial infarction, and a stent was placed in the proximal right coronary artery. He also had chronic total occlusion (CTO) of the left anterior descending artery (LAD). The planned LAD CTO intervention was complicated by balloon-induced coronary perforation and was managed successfully with intracoronary injection of Histoacryl-Lipiodol mixtures via microcatheter. He was discharged in stable condition without any serious consequences. Case 2 was a 72-year-old man with underlying hypertension who was admitted to the hospital with diagnosis of unstable angina. The diagnostic angiography showed occlusion of the LAD, CTO of the left circumflex artery, and minor atherosclerosis in right coronary artery. A stent was placed in the mid-LAD without any complications. Subsequently, a planned left circumflex artery CTO intervention was complicated by wire-induced coronary perforation, which was treated successfully with injection of Histoacryl-Lipiodol mixture. The patient was discharged in good condition. CONCLUSIONS Histoacryl and Lipiodol injection was a rapid and effective management method in 2 rare cases of coronary artery perforation during percutaneous coronary intervention.

摘要

背景

经皮冠状动脉介入治疗(PCI)中冠状动脉穿孔是一种罕见的并发症。本报告介绍了 2 例成功应用Histoacryl(正丁基-2-氰基丙烯酸酯)和Lipiodol(碘油)混合注射治疗的 PCI 术中冠状动脉穿孔病例。

病例报告

病例 1 为 51 岁男性,既往有高血压、血脂异常和多支血管性心脏病病史。因下壁心肌梗死入院,于右冠状动脉近端置入支架,同时存在左前降支(LAD)慢性完全闭塞(CTO)病变。拟行 LAD CTO 介入治疗时发生球囊诱导的冠状动脉穿孔,通过微导管成功进行了冠状动脉内Histoacryl-Lipiodol 混合液注射治疗,患者病情稳定出院,未出现严重后果。病例 2 为 72 岁男性,有基础高血压病史,因不稳定型心绞痛入院。诊断性冠状动脉造影显示 LAD 闭塞、左回旋支 CTO 和右冠状动脉轻度粥样硬化。于 LAD 中段成功置入支架,随后计划行左回旋支 CTO 介入治疗时发生导丝诱导的冠状动脉穿孔,通过注射Histoacryl-Lipiodol 混合液成功治疗,患者病情稳定出院。

结论

在 2 例罕见的 PCI 术中冠状动脉穿孔病例中,Histoacryl 和 Lipiodol 注射是一种快速有效的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/eba029f10533/amjcaserep-24-e938861-v004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/83a254d223ff/amjcaserep-24-e938861-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/910289f6009e/amjcaserep-24-e938861-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/019fd72d9880/amjcaserep-24-e938861-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/7c1db8a48426/amjcaserep-24-e938861-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/59136b027fb3/amjcaserep-24-e938861-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/3af59d844d58/amjcaserep-24-e938861-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/2b2e8e062a34/amjcaserep-24-e938861-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/df412f881228/amjcaserep-24-e938861-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/8f3700aa3927/amjcaserep-24-e938861-v001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/67978edd4d57/amjcaserep-24-e938861-v002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/0296682a1c26/amjcaserep-24-e938861-v003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/eba029f10533/amjcaserep-24-e938861-v004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/83a254d223ff/amjcaserep-24-e938861-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/910289f6009e/amjcaserep-24-e938861-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/019fd72d9880/amjcaserep-24-e938861-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/7c1db8a48426/amjcaserep-24-e938861-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/59136b027fb3/amjcaserep-24-e938861-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/3af59d844d58/amjcaserep-24-e938861-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/2b2e8e062a34/amjcaserep-24-e938861-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/df412f881228/amjcaserep-24-e938861-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/8f3700aa3927/amjcaserep-24-e938861-v001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/67978edd4d57/amjcaserep-24-e938861-v002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/0296682a1c26/amjcaserep-24-e938861-v003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f24/9901490/eba029f10533/amjcaserep-24-e938861-v004.jpg

相似文献

1
Two Cases of Management of Coronary Artery Perforation During Percutaneous Coronary Intervention Using Injection of Combined Histoacryl (n-Butyl-2-Cyanoacrylate) and Lipiodol (Ethiodized Oil).两例经皮冠状动脉介入治疗中应用注射混合Histoacryl(正丁基-2-氰基丙烯酸酯)和Lipiodol(碘油)治疗冠状动脉穿孔的病例。
Am J Case Rep. 2023 Feb 3;24:e938861. doi: 10.12659/AJCR.938861.
2
Use of "super-glue" to seal a perforation during chronic total occlusion coronary intervention and the potential to "unglue" it.使用“超级胶水”在慢性完全闭塞冠状动脉介入治疗期间封闭穿孔,以及潜在的“解胶”能力。
Catheter Cardiovasc Interv. 2020 May 1;95(6):1136-1140. doi: 10.1002/ccd.28399. Epub 2019 Jul 16.
3
Successful percutaneous coronary intervention to the left anterior descending artery in-stent chronic total occlusion via the left internal mammary artery graft: a case report.经左乳内动脉桥对左前降支支架内慢性完全闭塞病变成功进行经皮冠状动脉介入治疗:一例报告
Eur Heart J Case Rep. 2022 Feb 7;6(2):ytac049. doi: 10.1093/ehjcr/ytac049. eCollection 2022 Feb.
4
Right coronary artery perforation extending to the coronary sinus of Valsalva during percutaneous intervention successfully sealed with polytetrafluoroethylene-covered stent: a case report.经皮介入治疗期间右冠状动脉穿孔延伸至主动脉窦的冠状窦,使用聚四氟乙烯覆膜支架成功封堵:一例病例报告
BMC Res Notes. 2017 Oct 30;10(1):537. doi: 10.1186/s13104-017-2867-3.
5
Coronary artery perforation after bioresorbable scaffold implantation treated with a new generation covered stent-OCT insights.生物可吸收支架植入后冠状动脉穿孔的治疗:新一代覆膜支架——OCT 观察。
BMC Cardiovasc Disord. 2022 Feb 23;22(1):66. doi: 10.1186/s12872-022-02501-3.
6
Treatment of coronary pseudoaneurysm detected after percutaneous coronary intervention for chronic total occlusion: A case report.经皮冠状动脉介入治疗慢性完全闭塞后发现冠状动脉假性动脉瘤的治疗:一例报告。
Medicine (Baltimore). 2023 Mar 3;102(9):e32839. doi: 10.1097/MD.0000000000032839.
7
Microcatheter balloon pinning technique to facilitate wiring of a left circumflex chronic total occlusion.微导管球囊固定技术辅助左回旋支慢性完全闭塞病变的导丝通过。
Cardiovasc Ther. 2017 Dec;35(6). doi: 10.1111/1755-5922.12290.
8
Ellis type 4 coronary artery perforation during percutaneous coronary intervention: Case series and review.经皮冠状动脉介入治疗中 Ellis 4 型冠状动脉穿孔:病例系列和综述。
Catheter Cardiovasc Interv. 2023 Dec;102(7):1252-1258. doi: 10.1002/ccd.30873. Epub 2023 Nov 10.
9
Coronary artery perforation during chronic total occlusion percutaneous coronary intervention: epidemiology, mechanisms, management, and outcomes.冠状动脉慢性完全闭塞介入治疗中发生的冠状动脉穿孔:流行病学、机制、处理和结果。
EuroIntervention. 2019 Oct 4;15(9):e804-e811. doi: 10.4244/EIJ-D-19-00282.
10
Distal Coronary Perforation Sealing With Combined Coil and Fat Embolization.联合使用弹簧圈和脂肪栓塞术封堵冠状动脉远端穿孔
Cardiovasc Revasc Med. 2022 Jul;40S:222-224. doi: 10.1016/j.carrev.2021.12.001. Epub 2021 Dec 7.

引用本文的文献

1
Case Report: An innovative approach to coronary artery perforation in chronic total occlusion using autologous flaps.病例报告:一种使用自体皮瓣治疗慢性完全闭塞冠状动脉穿孔的创新方法。
Front Cardiovasc Med. 2025 May 27;12:1594967. doi: 10.3389/fcvm.2025.1594967. eCollection 2025.

本文引用的文献

1
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021 ACC/AHA/SCAI 冠状动脉血运重建指南:执行摘要:美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2022 Jan 18;145(3):e4-e17. doi: 10.1161/CIR.0000000000001039. Epub 2021 Dec 9.
2
Portal vein embolization with N-butyl cyanoacrylate glue is superior to other materials: a systematic review and meta-analysis.经皮经肝门静脉栓塞术联合氰基丙烯酸正丁酯胶优于其他材料:系统评价和荟萃分析。
Eur Radiol. 2021 Aug;31(8):5464-5478. doi: 10.1007/s00330-020-07685-w. Epub 2021 Jan 26.
3
Chronic total occlusion percutaneous coronary intervention: managing perforation complications.
慢性完全闭塞经皮冠状动脉介入治疗:穿孔并发症的处理。
Expert Rev Cardiovasc Ther. 2021 Jan;19(1):71-87. doi: 10.1080/14779072.2021.1850264. Epub 2021 Jan 4.
4
Use of "super-glue" to seal a perforation during chronic total occlusion coronary intervention and the potential to "unglue" it.使用“超级胶水”在慢性完全闭塞冠状动脉介入治疗期间封闭穿孔,以及潜在的“解胶”能力。
Catheter Cardiovasc Interv. 2020 May 1;95(6):1136-1140. doi: 10.1002/ccd.28399. Epub 2019 Jul 16.
5
Procedural Success and Outcomes With Increasing Use of Enabling Strategies for Chronic Total Occlusion Intervention.随着慢性完全闭塞介入治疗中启用策略的使用增加,手术成功率和结果。
Circ Cardiovasc Interv. 2018 Oct;11(10):e006436. doi: 10.1161/CIRCINTERVENTIONS.118.006436.
6
Portal vein embolization using a Histoacryl/Lipiodol mixture before right liver resection.术前使用Histoacryl/Lipiodol 混合物行门静脉栓塞术以切除右肝。
Dig Surg. 2012;29(3):236-42. doi: 10.1159/000339748. Epub 2012 Jul 12.
7
Incidence, predictors, management, immediate and long-term outcomes following grade III coronary perforation.III 级冠状动脉穿孔的发生率、预测因素、处理、即刻和长期结局。
JACC Cardiovasc Interv. 2011 Jan;4(1):87-95. doi: 10.1016/j.jcin.2010.08.026.
8
Incidence, predictors, in-hospital, and late outcomes of coronary artery perforations.冠状动脉穿孔的发生率、预测因素、住院期间及远期结局
Am J Cardiol. 2004 Jan 15;93(2):213-6. doi: 10.1016/j.amjcard.2003.09.042.
9
Coronary artery perforation during percutaneous intervention: incidence and outcome.经皮介入治疗期间的冠状动脉穿孔:发生率及结局
Heart. 2002 Nov;88(5):495-8. doi: 10.1136/heart.88.5.495.
10
Increased coronary perforation in the new device era. Incidence, classification, management, and outcome.新器械时代冠状动脉穿孔增加。发生率、分类、处理及结局
Circulation. 1994 Dec;90(6):2725-30. doi: 10.1161/01.cir.90.6.2725.